Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Novel biologic Ab-IPL-IL-17™ shows promise for rheumatoid arthritis and inflammatory bowel disease The antibody targets a section of signalling proteins that play a central role in sustaining inflammation during onset and progression of autoimmune diseases
News UK and Ireland-wide network to advance ‘urgently needed’ congenital heart disease clinical research
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
27 September 2023 Patients with Atrial High-Rate Episodes should not be treated with anticoagulant, trial finds The NOAH-AFNET 6 trial shows that giving a direct oral anticoagulant to patients with these device-detected arrhythmias has no benefits and increases risks.
14 September 2023 New grant award to find better treatments for thrombo-inflammatory diseases Birmingham researchers will target Galectin-9, a protein involved in thrombo-inflammation processes.
15 August 2023 Novel biologic Ab-IPL-IL-17™ shows promise for rheumatoid arthritis and inflammatory bowel disease The antibody targets a section of signalling proteins that play a central role in sustaining inflammation during onset and progression of autoimmune diseases
31 July 2023 New partnership to advance research into IBD Researchers from the University of Birmingham will work with Roche to identify new avenues for treatment for Inflammatory Bowel Disease.
31 July 2023 UK and Ireland-wide network to advance ‘urgently needed’ congenital heart disease clinical research A new national strategy document, released today, should help aid progress in congenital heart disease research through greater collaboration between centres.
13 June 2023 Immune cell movement worse in older females, mice study finds First study to show ageing is factor in sex differences between immune cell movement around the body
10 May 2023 AI-powered personalised medicine tool for hypertension being developed Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.